Showing results (51-60 of 61) with videos related to
Sort By:
Pageof 7
Molecular and Cellular Biology|November 13, 2003
GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancerYoshimitsu Akiyama, Neil Watkins, Hiromu Suzuki, et al.Plos One|March 21, 2012
Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancerMing-yang Song, Kai-feng Pan, Hui-juan Su, et al.Cancer Research|March 16, 2013
Inhibition of histone demethylase JMJD1A improves anti-angiogenic therapy and reduces tumor-associated macrophagesTsuyoshi Osawa, Rika Tsuchida, Masashi Muramatsu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 11, 2014
Large-scale characterization of DNA methylation changes in human gastric carcinomas with and without metastasisZhaojun Liu, Jun Zhang, Yanhong Gao, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 3, 2014
Methylation status of blood leukocyte DNA and risk of gastric cancer in a high-risk Chinese populationYang Zhang, Hui-Juan Su, Kai-Feng Pan, et al.International Journal of Cancer|March 27, 2012
Insulin-like growth factor 2 hypomethylation of blood leukocyte DNA is associated with gastric cancer riskYasuhito Yuasa, Hiromi Nagasaki, Isao Oze, et al.Oncotarget|December 25, 2015
Reduced expression of SET7/9, a histone mono-methyltransferase, is associated with gastric cancer progressionYoshimitsu Akiyama, Yuki Koda, Sun-Ju Byeon, et al.Journal of Epidemiology|August 7, 2012
DNA methylation in peripheral blood: a potential biomarker for cancer molecular epidemiologyLian Li, Ji-Yeob Choi, Kyoung-Mu Lee, et al.Plos One|September 10, 2013
CD49f(high) cells retain sphere-forming and tumor-initiating activities in human gastric tumorsHiroshi Fukamachi, Hyang Sook Seol, Shu Shimada, et al.Journal of Experimental & Clinical Cancer Research : CR|March 15, 2019
A subset of diffuse-type gastric cancer is susceptible to mTOR inhibitors and checkpoint inhibitorsHiroshi Fukamachi, Seon-Kyu Kim, Jiwon Koh, et al.Pageof 7